POLE and cancer: A missense somatic mutation call in POLE with an AF of 0.25 in the cancer sample of the A16 case may account for only a part of the story, since the mutational spectra tell us that the mutations in POLE gene happened early in the evolution for such patterns to form both in adenoma and in cancer.